Evaluation of anti-cancer activity of two new biuret derivatives against T47D and K562 cell lines in the presence of natural killer cells
Abstract
Full Text:
PDFRefbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.